Posted inDiabetes & Endocrinology news Specialties
Heart Risks Uncovered: Popular Diabetes Drug Glipizide Linked to Higher Cardiovascular Events, Study Reveals
Recent research reveals glipizide, a common diabetes drug, increases cardiovascular risks compared to DPP-4 inhibitors. This challenges assumptions about sulfonylureas, urging personalized treatment considering heart health alongside glycemic control in type 2 diabetes management.